Home / Restalyst / Restalyst received Singapore HSA Provisional Authorization approval for COVID19-REAAD™ Anti-SARS-CoV-2 IgG ELISA

June 29, 2021 Restalyst

This is a product intended for qualitative & quantitative detection of IgG antibodies to SARS-CoV-2 proteins in human serum and plasma.